| 100019-9 | ALK gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100020-7 | GNA11 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100021-5 | GNAQ gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100022-3 | IDH1 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100023-1 | IDH2 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100024-9 | SETBP1 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100025-6 | SRSF2 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100026-4 | MET gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100027-2 | SMAD4 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100028-0 | FBXW7 gene mutations found or Tissue (Blood, molecular genetics method nominal) |
| 100213-8 | Prostate cancer multigene analysis or Tissue (Blood, molecular genetics method) |
| 100694-9 | SMN1 gene silent carrier analysis or Tissue (Blood, qualitative, molecular genetics method) |
| 100695-6 | Genetic disease analysis overall carrier interpretation or Tissue (Blood, molecular genetics method narrative) |
| 100717-8 | FCGR3A gene.p.Phe176Val or Tissue (Blood, qualitative, molecular genetics method) |
| 100754-1 | Platelet disorders multigene analysis or Tissue (Blood, sequencing) |
| 100761-6 | PALB2 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101141-0 | NAT2 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101142-8 | NAT2 gene allele or Tissue (Blood, molecular genetics method nominal) |
| 101143-6 | NAT2 gene product metabolic activity interpretation or Tissue Qualitative (Blood, qualitative, molecular genetics method) |
| 101152-7 | Mitochondria whole genome analysis or Tissue (Blood, molecular genetics method) |
| 101224-4 | PKD1 and PKD2 gene deletion and duplication mutation analysis or Tissue (Blood, mlpa) |
| 101239-2 | Mean chromosome banding resolution or Tissue (Blood, banding) |
| 101379-6 | DDIT3 gene rearrangement or Tissue (Blood, fish) |
| 101381-2 | BAP1 gene deletion+duplication and full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101382-0 | FH gene deletion+duplication and full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101383-8 | FUS gene rearrangements or Tissue (Blood, fish) |
| 101385-3 | NF1 gene deletion+duplication and full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101386-1 | RET gene deletion+duplication and full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101387-9 | HBA1 and HBA2 gene full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101388-7 | GP1BB full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101389-5 | GP1BA gene full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101390-3 | GP9 gene full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101391-1 | PAH gene full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101392-9 | ADA gene full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101393-7 | CLCN7 gene full mutation analysis or Tissue (Blood, molecular genetics method) |
| 101397-8 | Copy number variation analysis or Tissue (Blood, sequencing) |
| 101547-8 | Hepatocyte Paraffin 1 Ab or Tissue Qualitative (Blood, qualitative, immune stain) |
| 101548-6 | P63 protein or Tissue Qualitative (Blood, qualitative) |
| 101590-8 | VKORC1 gene allele or Tissue (Blood, molecular genetics method nominal) |
| 101631-0 | JAK2 gene rearrangements or Tissue (Blood, fish) |
| 101633-6 | MT-RNR1 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101634-4 | HBB gene deletion and duplication mutation analysis or Tissue (Blood, mlpa) |
| 101635-1 | USP6 gene rearrangements or Tissue (Blood, fish) |
| 101637-7 | TCRB gene and TCRG gene rearrangements or Tissue (Blood, molecular genetics method) |
| 101639-3 | PDGFB gene rearrangements or Tissue (Blood, fish) |
| 101640-1 | NUTM1 gene rearrangements or Tissue (Blood, fish) |
| 101641-9 | Myeloid sarcoma analysis or Tissue (Blood, fish) |
| 101663-3 | T-Cell acute lymphoblastic leukemia or Tissue (Blood, fish) |
| 101664-1 | in Blood or Tissue (fish) |
| 101671-6 | Hereditary Wilms tumor multigene analysis or Tissue (Blood, molecular genetics method) |
| 101682-3 | T-cell lymphoma or Tissue Document (Blood, fish) |
| 101785-4 | CYP2C Cluster Allele or Tissue (Blood, molecular genetics method) |
| 101952-0 | MTTP gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101953-8 | COL4A3 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101954-6 | SLC35A3 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101955-3 | DNAI1 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101956-1 | COQ4 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101957-9 | RTEL1 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101958-7 | ADAMTS2 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101959-5 | TCIRG1 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101960-3 | PEX2 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101961-1 | PHGDH gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101962-9 | DHDDS gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101963-7 | SLC1A4 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101964-5 | HPS3 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 101965-2 | NDUFAF5 gene targeted mutation analysis or Tissue (Blood, molecular genetics method) |
| 102038-7 | ROS proto-oncogene 1 mutations found or Tissue (Blood, molecular genetics method nominal) |
| 102039-5 | MET gene amplification or Tissue (Blood, molgen) |
| 102092-4 | HLA-ABDR typing panel - Blood or Tissue |
| 102096-5 | HLA-DQA1 SSO panel - Blood or Tissue (naa with probe detection) |
| 102099-9 | B-cell acute lymphocytic leukemia or Tissue (Blood, fish) |
| 102100-5 | B-cell acute lymphoblastic leukemia or Tissue (Blood, fish) |
| 102101-3 | Acute myeloid leukemia or Tissue (Blood, fish) |
| 102103-9 | Acute myeloid leukemia panel - Blood or Tissue (fish) |
| 102118-7 | Rhabdomyolysis and Metabolic myopathy multigene panel - Blood or Tissue (molecular genetics method) |
| 102119-5 | Skeletal muscle channelopathy multigene panel - Blood or Tissue (molecular genetics method) |
| 103143-4 | Genetic disease DNA and RNA analysis or Tissue (Blood, qualitative, molecular genetics method) |
| 103558-3 | NR4A3 gene rearrangements or Tissue (Blood, fish) |
| 103621-9 | Small lymphocytic lymphoma chromosome deletions AndOr rearrangements or Tissue (Blood, fish) |
| 103677-1 | HMEP-Hemiplegic migraine multigene analysis or Tissue (Blood, molecular genetics method) |
| 103680-5 | TP53 gene full mutation analysis or Tissue (Blood, molecular genetics method) |
| 103727-4 | Hereditary Motor Neuropathy multigene analysis or Tissue (Blood, molecular genetics method) |
| 103728-2 | Hereditary motor and sensory neuropathy multigene analysis or Tissue (Blood, molecular genetics method) |
| 103729-0 | Hereditary sensory neuropathy multigene analysis or Tissue (Blood, molecular genetics method) |
| 103730-8 | Hereditary spastic paraplegia multigene analysis or Tissue (Blood, molecular genetics method) |
| 103731-6 | Distal weakness multigene analysis or Tissue (Blood, molecular genetics method) |
| 103732-4 | Hereditary congenital myasthenic syndrome multigene analysis or Tissue (Blood, molecular genetics method) |
| 103733-2 | Hereditary emery dreifuss multigene analysis or Tissue (Blood, molecular genetics method) |
| 103739-9 | EBV Lymphoproliferation multigene analysis or Tissue (Blood, molecular genetics method) |
| 104171-4 | DPYD gene.c.2846A>T or Tissue (Blood, molecular genetics method nominal) |
| 104172-2 | DPYD gene.c.1236G>A or Tissue (Blood, molecular genetics method nominal) |
| 104173-0 | DPYD gene.c.1905+1G>A or Tissue (Blood, molecular genetics method nominal) |
| 104174-8 | DPYD gene.c.1679T>G or Tissue (Blood, molecular genetics method nominal) |
| 104225-8 | HLA-DPB1+DPA1 Typing panel - Blood or Tissue |
| 104238-1 | Chronic and low grade B cell lymphoid neoplasm multigene analysis or Tissue (Blood, molecular genetics method) |
| 104239-9 | B cell non hodgkin Lymphoma multigene analysis or Tissue (Blood, molecular genetics method) |
| 104240-7 | Histiocytic neoplasm multigene analysis or Tissue (Blood, molecular genetics method) |
| 104242-3 | T cell lymphoma multigene analysis or Tissue (Blood, molecular genetics method) |
| 104276-1 | ALK gene mutations tested for or Tissue (Blood, molecular genetics method nominal) |
| 104277-9 | MET gene mutations tested for or Tissue (Blood, molecular genetics method nominal) |